Literature DB >> 30909225

Cognitive Performance in Parkinson's Disease in the Brain Health Registry.

Brenna Cholerton1, Michael W Weiner2,3,4,5, Rachel L Nosheny2,4, Kathleen L Poston6, R Scott Mackin2,4, Lu Tian7, J Wesson Ashford8,9, Thomas J Montine1.   

Abstract

The study of cognition in Parkinson's disease (PD) traditionally requires exhaustive recruitment strategies. The current study examines data collected by the Brain Health Registry (BHR) to determine whether ongoing efforts to improve the recruitment base for therapeutic trials in Alzheimer's disease may be similarly effective for PD research, and whether online cognitive measurements can discriminate between participants who do and do not report a PD diagnosis. Participants enrolled in the BHR (age ≥50) with self-reported PD data and online cognitive testing available were included (n = 11,813). Associations between baseline cognitive variables and diagnostic group were analyzed using logistic regression. Linear mixed effects models were used to analyze longitudinal data. A total of 634 participants reported PD diagnosis at baseline with no self-reported cognitive impairment and completed cognitive testing. Measures of visual learning and memory, processing speed, attention, and working memory discriminated between self-reported PD and non-PD participants after correcting for multiple comparisons (p values < 0.006). Scores on all cognitive tests improved over time in PD and controls with the exception of processing speed, which remained stable in participants with PD while improving in those without. We demonstrate that a novel online approach to recruitment and longitudinal follow-up of study participants is effective for those with self-reported PD, and that significant differences exist between those with and without a reported diagnosis of PD on computerized cognitive measures. These results have important implications for recruitment of participants with PD into targeted therapeutic trials or large-scale genetic and cognitive studies.

Entities:  

Keywords:  Aging; Parkinson’s disease; cognition; neuropsychology; patient selection; registries

Year:  2019        PMID: 30909225      PMCID: PMC6497062          DOI: 10.3233/JAD-181009

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  26 in total

Review 1.  Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience.

Authors:  G Webster Ross; Robert D Abbott; Helen Petrovitch; Caroline M Tanner; Lon R White
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Measuring memory in large group settings using a continuous recognition test.

Authors:  J Wesson Ashford; Emily Gere; Peter J Bayley
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.

Authors:  Yen Ying Lim; Kathryn A Ellis; Karra Harrington; David Ames; Ralph N Martins; Colin L Masters; Christopher Rowe; Greg Savage; Cassandra Szoeke; David Darby; Paul Maruff
Journal:  J Clin Exp Neuropsychol       Date:  2012-01-17       Impact factor: 2.475

Review 4.  Brain structural MRI correlates of cognitive dysfunctions in Parkinson's disease.

Authors:  Naroa Ibarretxe-Bilbao; Carme Junque; Maria J Marti; Eduardo Tolosa
Journal:  J Neurol Sci       Date:  2011-08-23       Impact factor: 3.181

5.  Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics.

Authors:  Brenna A Cholerton; Cyrus P Zabetian; Joseph F Quinn; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; Karen L Edwards; Thomas J Montine; James B Leverenz
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

6.  The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.

Authors:  Mariese A Hely; Wayne G J Reid; Michael A Adena; Glenda M Halliday; John G L Morris
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

7.  Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.

Authors:  Pekka Jokinen; Mira Karrasch; Anna Brück; Jarkko Johansson; Jörgen Bergman; Juha O Rinne
Journal:  J Neurol Sci       Date:  2013-04-03       Impact factor: 3.181

8.  Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

Authors:  D Aarsland; K Brønnick; J P Larsen; O B Tysnes; G Alves
Journal:  Neurology       Date:  2008-11-19       Impact factor: 9.910

9.  Brain volumetric correlates of memory in early Parkinson's disease.

Authors:  Ulla Ellfolk; Juho Joutsa; Juha O Rinne; Riitta Parkkola; Pekka Jokinen; Mira Karrasch
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

Review 10.  Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

Authors:  Amy Reeve; Eve Simcox; Doug Turnbull
Journal:  Ageing Res Rev       Date:  2014-02-03       Impact factor: 10.895

View more
  1 in total

1.  Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson's disease.

Authors:  Brenna A Cholerton; Kathleen L Poston; Laurice Yang; Liana S Rosenthal; Ted M Dawson; Alexander Pantelyat; Karen L Edwards; Lu Tian; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Shu-Ching Hu; Thomas J Montine; Cyrus P Zabetian
Journal:  J Clin Exp Neuropsychol       Date:  2021-08-06       Impact factor: 2.283

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.